The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Overactive Bladder Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
The global Overactive Bladder Treatment market size is expected to reach US$ 6287.9 million by 2029, growing at a CAGR of 3.0% from 2023 to 2029. The market is mainly driven by the significant applications of Overactive Bladder Treatment in various end use industries. The expanding demands from the Idiopathic Overactive Bladder and Neurogenic Overactive Bladder, are propelling Overactive Bladder Treatment market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Device segment is estimated at % CAGR for the next seven-year period.
Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Overactive Bladder Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Overactive Bladder Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Overactive Bladder Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Overactive Bladder Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Overactive Bladder Treatment covered in this report include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic and KYORIN Pharmaceutical, etc.
The global Overactive Bladder Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Medtronic
KYORIN Pharmaceutical
Global Overactive Bladder Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Overactive Bladder Treatment market, Segment by Type:
Drugs
Device
Global Overactive Bladder Treatment market, by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Overactive Bladder Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device.
The global Overactive Bladder Treatment market size is expected to reach US$ 6287.9 million by 2029, growing at a CAGR of 3.0% from 2023 to 2029. The market is mainly driven by the significant applications of Overactive Bladder Treatment in various end use industries. The expanding demands from the Idiopathic Overactive Bladder and Neurogenic Overactive Bladder, are propelling Overactive Bladder Treatment market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Device segment is estimated at % CAGR for the next seven-year period.
Global Overactive Bladder Treatment key players include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic, etc. Global top five manufacturers hold a share about 90%. United States is the largest market, with a share about 60%, followed by Europe, with a share about 15 percent. In terms of product, Drugs is the largest segment, with a share about 95%. And in terms of application, the largest application is Idiopathic Overactive Bladder, followed by Neurogenic Overactive Bladder.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Overactive Bladder Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Overactive Bladder Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Overactive Bladder Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Overactive Bladder Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Overactive Bladder Treatment covered in this report include Allergan, Astellas Pharma, Pfizer, Johnson & Johnson, Medtronic and KYORIN Pharmaceutical, etc.
The global Overactive Bladder Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan
Astellas Pharma
Pfizer
Johnson & Johnson
Medtronic
KYORIN Pharmaceutical
Global Overactive Bladder Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Overactive Bladder Treatment market, Segment by Type:
Drugs
Device
Global Overactive Bladder Treatment market, by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Overactive Bladder Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Overactive Bladder Treatment
1.1 Overactive Bladder Treatment Market Overview
1.1.1 Overactive Bladder Treatment Product Scope
1.1.2 Overactive Bladder Treatment Market Status and Outlook
1.2 Global Overactive Bladder Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Overactive Bladder Treatment Market Size by Region (2018-2029)
1.4 Global Overactive Bladder Treatment Historic Market Size by Region (2018-2023)
1.5 Global Overactive Bladder Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Overactive Bladder Treatment Market Size (2018-2029)
1.6.1 North America Overactive Bladder Treatment Market Size (2018-2029)
1.6.2 Europe Overactive Bladder Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Overactive Bladder Treatment Market Size (2018-2029)
1.6.4 Latin America Overactive Bladder Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Overactive Bladder Treatment Market Size (2018-2029)
2 Overactive Bladder Treatment Market by Type
2.1 Introduction
2.1.1 Drugs
2.1.2 Device
2.2 Global Overactive Bladder Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Overactive Bladder Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Overactive Bladder Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Overactive Bladder Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Overactive Bladder Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Overactive Bladder Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Overactive Bladder Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Overactive Bladder Treatment Revenue Breakdown by Type (2018-2029)
3 Overactive Bladder Treatment Market Overview by Application
3.1 Introduction
3.1.1 Idiopathic Overactive Bladder
3.1.2 Neurogenic Overactive Bladder
3.2 Global Overactive Bladder Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Overactive Bladder Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Overactive Bladder Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Overactive Bladder Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Overactive Bladder Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Overactive Bladder Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Overactive Bladder Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Overactive Bladder Treatment Revenue Breakdown by Application (2018-2029)
4 Overactive Bladder Treatment Competition Analysis by Players
4.1 Global Overactive Bladder Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Overactive Bladder Treatment as of 2022)
4.3 Date of Key Players Enter into Overactive Bladder Treatment Market
4.4 Global Top Players Overactive Bladder Treatment Headquarters and Area Served
4.5 Key Players Overactive Bladder Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Overactive Bladder Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Allergan
5.1.1 Allergan Profile
5.1.2 Allergan Main Business
5.1.3 Allergan Overactive Bladder Treatment Products, Services and Solutions
5.1.4 Allergan Overactive Bladder Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Allergan Recent Developments
5.2 Astellas Pharma
5.2.1 Astellas Pharma Profile
5.2.2 Astellas Pharma Main Business
5.2.3 Astellas Pharma Overactive Bladder Treatment Products, Services and Solutions
5.2.4 Astellas Pharma Overactive Bladder Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Astellas Pharma Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Overactive Bladder Treatment Products, Services and Solutions
5.3.4 Pfizer Overactive Bladder Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Overactive Bladder Treatment Products, Services and Solutions
5.4.4 Johnson & Johnson Overactive Bladder Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Medtronic
5.5.1 Medtronic Profile
5.5.2 Medtronic Main Business
5.5.3 Medtronic Overactive Bladder Treatment Products, Services and Solutions
5.5.4 Medtronic Overactive Bladder Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Medtronic Recent Developments
5.6 KYORIN Pharmaceutical
5.6.1 KYORIN Pharmaceutical Profile
5.6.2 KYORIN Pharmaceutical Main Business
5.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Products, Services and Solutions
5.6.4 KYORIN Pharmaceutical Overactive Bladder Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 KYORIN Pharmaceutical Recent Developments
6 North America
6.1 North America Overactive Bladder Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Overactive Bladder Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Overactive Bladder Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Overactive Bladder Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Overactive Bladder Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Overactive Bladder Treatment Market Dynamics
11.1 Overactive Bladder Treatment Industry Trends
11.2 Overactive Bladder Treatment Market Drivers
11.3 Overactive Bladder Treatment Market Challenges
11.4 Overactive Bladder Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
